ABO and COVID-19: These results suggest a possible involvement of ABO and Duffy red blood cell antigens in SARS-CoV-2 susceptibility and COVID-19 severity, as all these individuals contracted the virus, yet only had mild symptoms, and cleared the infection without needing hospitalization.